Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
dihexa hgf/c-met potentiator

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues

Hepatocyte Growth Factor MET Activator Rescues Working Memory Deficits After Repeated Mild Traumatic Brain Injury bioRxiv The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link HGF and MET: From Brain Development to Neurological Disorders PMC Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect

SKU: 9933087528 · From southroadsurgery.com.au

4.7
USD29.59 USD77.59

Pay in 4 interest-free payments of $7.40 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Protein and amino acids

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues

EMBO Journal 31, 15061517

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues

Besides, HSPA1, previously known anti-proliferative factor with JAK/STAT pathway involved, is additionally reported to mediate the angiogenic effect of interleukin-28A in vitro and in vivo via the eNOS/AKT signaling pathway and the activator protein-1/nuclear factor-B/matrix metalloproteinase-2 (AP-1/NF-B/MMP-2) cascade (Song et al., 2025)

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues

Cagrilintide has shown a favorable tolerability profile

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues

Visual acuity comparisons were made in logMAR units, with each line of improvement in acuity corresponding to a logMAR reduction of 0.1

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues

In this work, we assessed neurotrophin levels (i.e., BDNF and proBDNF) in individuals with CUD and matched healthy controls

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte Growth Factor/MET Activator Rescues
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products